Neova Biogene Private Limited logo

Neova Biogene Private Limited

Pharmaceutical company offering medicines in oncology, nephrology, anti-fungal, anti-viral, and more.
2021 | Mumbai, Maharashtra (India) | Active

Last Updated:

October 29, 2024
HomeCompanyNeova Biogene Private Limited

Who are the key members and board of directors at Neova Biogene?

Board Members(2)

NameDesignationAppointment DateStatus
Arvindsingh Thakur In Director 23-Mar-2021Current
Raj Thakur In Director 01-Dec-2022Current

Financial Performance of Neova Biogene.

Neova Biogene Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 264.77% increase. The company also saw a substantial fall in profitability, with a 1308.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 3098.71%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
264.77%
Revenue from Operations
264.76%
Total Assets
262.43%
Profit or Loss
-1308.46%
Net Worth
-3098.71%
EBITDA
-4289.02%

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Neova Biogene?

Neova Biogene has a workforce of 19 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Neova Biogene

Recent activity within the organization

  • Annual General Meeting

    Neova Biogene Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Neova Biogene Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Director Appointment

    Raj Pratap Bhureysingh Thakur was appointed as a Director was appointed as a Director on 01 Dec 2022 & has been associated with this company since 2 years 29 days .

    01 Dec 2022

  • Director Appointment

    Arvindsingh Bhureysingh Thakur was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 3 years 9 months .

    23 Mar 2021

  • Company Incorporation

    Neova Biogene Private Limited was registered on 23 Mar 2021 with Roc Mumbai & aged 3 years 9 months as per MCA records.

    23 Mar 2021

Frequently asked questions

  • Neova Biogene Private Limited was incorporated on 23 Mar 2021.

  • The authorized share capital of Neova Biogene Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Neova Biogene Private Limited.

    • Arvindsingh Bhureysingh Thakur
    • Raj Pratap Bhureysingh Thakur
  • As per Ministry of Corporate Affairs (Mca), the registered address of Neova Biogene Private Limited is Office No 322 Marathon Monte Plaza Madan Mohan Suburban, Greater India, Mumbai, Maharashtra, 400080.

  • The corporate identification number (CIN) of Neova Biogene Private Limited is U24299MH2021PTC357718 and the company number is 357718 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Neova Biogene Private Limited is https://www.neovabiogene.in

  • According to the financial reports for the fiscal year 2023, the revenue trend for Neova Biogene Private Limited has risen by 264.77%.

  • As Per 2023 financial reports, 19 employees are currently employed by Neova Biogene Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Neova Biogene Private Limited has experienced an downturn of -3098.71%.

  • The most recent Balance Sheet for Neova Biogene Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development